Style | Citing Format |
---|---|
MLA | Mohammadi MK, et al.. "Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2)." DARU, Journal of Pharmaceutical Sciences, vol. 22, no. 1, 2014, pp. -. |
APA | Mohammadi MK, Firuzi O, Khoshneviszadeh M, Razzaghiasl N, Sepehri S, Miri R (2014). Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2). DARU, Journal of Pharmaceutical Sciences, 22(1), -. |
Chicago | Mohammadi MK, Firuzi O, Khoshneviszadeh M, Razzaghiasl N, Sepehri S, Miri R. "Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2)." DARU, Journal of Pharmaceutical Sciences 22, no. 1 (2014): -. |
Harvard | Mohammadi MK et al. (2014) 'Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2)', DARU, Journal of Pharmaceutical Sciences, 22(1), pp. -. |
Vancouver | Mohammadi MK, Firuzi O, Khoshneviszadeh M, Razzaghiasl N, Sepehri S, Miri R. Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2). DARU, Journal of Pharmaceutical Sciences. 2014;22(1):-. |
BibTex | @article{ author = {Mohammadi MK and Firuzi O and Khoshneviszadeh M and Razzaghiasl N and Sepehri S and Miri R}, title = {Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2)}, journal = {DARU, Journal of Pharmaceutical Sciences}, volume = {22}, number = {1}, pages = {-}, year = {2014} } |
RIS | TY - JOUR AU - Mohammadi MK AU - Firuzi O AU - Khoshneviszadeh M AU - Razzaghiasl N AU - Sepehri S AU - Miri R TI - Novel 9-(Alkylthio)-Acenaphtho[1,2-E]-1,2,4-Triazine Derivatives: Synthesis, Cytotoxic Activity and Molecular Docking Studies on B-Cell Lymphoma 2 (Bcl-2) JO - DARU, Journal of Pharmaceutical Sciences VL - 22 IS - 1 SP - EP - PY - 2014 ER - |